Themis Bioscience – Vaccines to prevent infectious diseases
MSD (Merck & Co., Inc.) acquired Themis
Themis Bioscience developed vaccines to prevent infectious diseases and combat cancer. Themis’ vaccine technology is based on science from the renowned vaccine research center at Institute Pasteur in Paris.
Industry
Therapeutics
Case facts
Location
Austria
Status
Exit June 2020